Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer (COPEC)

NCT04922853 PHASE3 ACTIVE_NOT_RECRUITING

To compare the pathological effect between 2 cycles and 4 cycles of Capox regimen as neoadjuvant chemotherapy for low/ intermediate risk stage II/III rectal cancer.

Details

Lead sponsor	West China Hospital
Phase	PHASE3
Status	ACTIVE_NOT_RECRUITING
Enrolment	554
Start date	Thu Aug 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Rectal Cancer
• Neoadjuvant Chemotherapy

Interventions

• Capox chemotherapy

Countries

China